11th Annual – Future of Genomic Medicine
March 1 – March 2, 2018 | La Jolla, California
Note – Online registration is now closed. Onsite registration will be available at the conference venue on March 1 & 2.
In collaboration with AAAS/Science Translational Medicine we invite you to another exciting two-day program on Thursday, March 1 and Friday, March 2, 2018 in beautiful San Diego, California. The 2018 program will again be held at the Scripps Institution of Oceanography.
The 11th annual Future of Genomic Medicine conference will be the next iteration of taking genomic knowledge to transform the daily practice of medicine. To do this, we have patients present their stories of how genomics affected their medical status, and have a faculty of experts in genomics, science and medical journalism, and the life science industry provide critical perspective. This year we will be paying attention to the exciting areas of genomic editing to treat diseases, cancer (a disease of the genome), and the use of genetics for preventative medicine. Furthermore, we will delve into the hot topics of circulating free DNA-based diagnostics, epigenetics, and genomic analytics. The overarching goal of the conference is to spearhead efforts to use genomic knowledge to change medicine and make it far more precise and individualized.
We look forward to your participation and another successful conference.
Ali Torkamani, PhD
After attending this activity, participants should be able to:
- Demonstrate the unmet needs of medicine today with respect to more targeted, individualized prevention and treatments.
- Discuss the opportunities of the genome, proteome, and metabolome discovery to change medical practice as it exists today.
- Assess how changes and advances in technology are rapidly ushering in a whole array of new pathways for individualized medicine of the future.
- Explore specific strategies in cancer, idiopathic and pharmacogenomic disease interventions.
- Human geneticists
- Genomic scientists
- Healthcare professionals of all disciplines interested in the future of medicine, especially with respect to individualized therapies